During the past decade, CAP Centelles conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CAP Centelles" #1 collaborator was "Eurofins Optimed" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CAP Centelles" are "COVID-19" (2 trials), "Cardiovascular Disease" (2 trials), "Clostridium Difficile Infection" (1 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "CAP Centelles" in a lesser frequency.

Most popular intervention types in "CAP Centelles" are "Drug" (4 trials), "Biological" (2 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "BNT162b2 20mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "CAP Centelles" are 7 trials for "All" genders.

Currently, there are NaN active trials in "CAP Centelles". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CAP Centelles, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CAP Centelles, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".